Related Experiment Video
Updated: May 26, 2026

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Multiple liver-specific factors bind to a 64-bp element and activate apo(a) gene
Vikas Handa1, Mahboob-ul-hussain, Nirupma Pati
1Centre for Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India.
Biochemical and Biophysical Research Communications
|March 14, 2002
Summary
High lipoprotein(a) [Lp(a)] levels link to atherosclerosis. Researchers identified a key liver-specific DNA region controlling the apo(a) gene, crucial for regulating Lp(a) concentration.
Area of Science:
- Molecular Biology
- Genetics
- Cardiovascular Research
Background:
- Elevated plasma lipoprotein(a) [Lp(a)] levels are a significant risk factor for atherosclerosis.
- The apolipoprotein(a) [apo(a)] gene dictates Lp(a) concentration, with its expression being liver-specific.
Purpose of the Study:
- To identify and characterize regulatory elements within the apo(a) gene promoter that control its liver-specific expression.
- To understand the molecular mechanisms underlying apo(a) gene regulation.
Main Methods:
- 5'-deletion analysis coupled with luciferase gene reporter assays to map regulatory regions.
- In vitro DNA-protein binding studies using UV cross-linking and streptavidin magnetic bead chromatography.
- Functional analysis in liver cells to assess gene activation.
Main Results:
- A 64-bp AT-rich region (-703 to -640) upstream of the apo(a) gene was identified as essential for liver-specific factor binding and gene activation.
- This cis-element contains three dyad symmetry elements (DSEs), with DSE-2 and DSE-3 being critical for synergistic factor binding and transcriptional activation.
- One liver-specific DNA-binding protein complex was purified.
- A negative regulatory region (-1432 to -704) was identified, suggesting the involvement of transcriptional repressors.
Conclusions:
- The identified 64-bp region and its DSEs are crucial for the transcriptional regulation of the apo(a) gene in the liver.
- The findings provide insights into the molecular mechanisms controlling Lp(a) levels and offer potential targets for therapeutic intervention in atherosclerosis.
- The existence of upstream negative regulatory elements indicates a complex regulatory network for apo(a) gene expression.
Related Concept Videos
Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Eukaryotic Transcription Activators
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Regulation of Nuclear Protein Sorting
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
General Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...

